摘要 |
The invention relates to anthracycline derivatives which have cytostatic activity and the formula I <IMAGE> and to the physiologically acceptable salts thereof, where R<1> is hydrogen or a hydroxyl group, R<2> is Cl, Br, OCOR<x>, NR<a>R<b>, NR<a>-(CH2)n-NR<a>R<b>, NR<a>-NR<a>-CO-(CH2)y-CO-NR<a>-NR<a>R<b> or NR<a>-CHR<3>R<4>, where R<x> is C1-C6-alkyl, phenyl or benzyl, n = 0-12 and y = 0-10, where R<a> and R<b> can each be hydrogen, C1-C4-alkyl or benzyl, and where R<3> is hydrogen or a carboxyl group and R<4> is the residue of an L-amino acid or a biogenic amine, to a process for the preparation thereof and to the use thereof in a pharmaceutical. |